These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 15176223

  • 1. [Expression of estrogen and progesterone receptors and oncoprotein HER-2 as a marker for clinical course and outcome in endometrioid adenocarcinoma of the uterine body (immunohistologic study)].
    Samsonova EA, Maksimova NA, Urmancheeva AF, Pozharisskiĭ KM.
    Vopr Onkol; 2004; 50(2):196-201. PubMed ID: 15176223
    [Abstract] [Full Text] [Related]

  • 2. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.
    Arpino G, Weiss H, Lee AV, Schiff R, De Placido S, Osborne CK, Elledge RM.
    J Natl Cancer Inst; 2005 Sep 07; 97(17):1254-61. PubMed ID: 16145046
    [Abstract] [Full Text] [Related]

  • 3. [Correlation between receptor status and results of treatment in endometrial carcinoma].
    Baĭnazarova AA, Iskakova ZhK.
    Vopr Onkol; 2006 Sep 07; 52(6):654-8. PubMed ID: 17338243
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prognostic implications of HER-2 status in steroid receptor-positive, lymph node-negative breast carcinoma.
    Peiró G, Adrover E, Aranda FI, Peiró FM, Niveiro M, Sánchez-Payá J.
    Am J Clin Pathol; 2007 May 07; 127(5):780-6. PubMed ID: 17439837
    [Abstract] [Full Text] [Related]

  • 7. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.
    Kyndi M, Sørensen FB, Knudsen H, Overgaard M, Nielsen HM, Overgaard J, Danish Breast Cancer Cooperative Group.
    J Clin Oncol; 2008 Mar 20; 26(9):1419-26. PubMed ID: 18285604
    [Abstract] [Full Text] [Related]

  • 8. Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma.
    Suthipintawong C, Wejaranayang C, Vipupinyo C.
    J Med Assoc Thai; 2008 Dec 20; 91(12):1779-84. PubMed ID: 19133508
    [Abstract] [Full Text] [Related]

  • 9. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
    Høgdall EV, Christensen L, Høgdall CK, Blaakaer J, Gayther S, Jacobs IJ, Christensen IJ, Kjaer SK.
    Oncol Rep; 2007 Nov 20; 18(5):1051-9. PubMed ID: 17914554
    [Abstract] [Full Text] [Related]

  • 10. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.
    BMC Cancer; 2007 Apr 12; 7():63. PubMed ID: 17430582
    [Abstract] [Full Text] [Related]

  • 11. [Immunohistochemical investigation of estrogen and progesterone receptors in breast tumors].
    Ellinidi VN, Anikseeva NV, Goncharova OA, Krasnozhon DA, Fedorov KA.
    Vopr Onkol; 2004 Apr 12; 50(2):234-6. PubMed ID: 15176229
    [Abstract] [Full Text] [Related]

  • 12. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.
    Bandić D, Juretić A, Sarcević B, Separović V, Kujundzić-Tiljak M, Hudolin T, Spagnoli GC, Cović D, Samija M.
    Croat Med J; 2006 Feb 12; 47(1):32-41. PubMed ID: 16489695
    [Abstract] [Full Text] [Related]

  • 13. Age interacts with the expression of steroid and HER-2 receptors in operable invasive breast cancer.
    Neven P, Van Calster B, Van den Bempt I, Van Huffel S, Van Belle V, Hendrickx W, Decock J, Wildiers H, Paridaens R, Amant F, Leunen K, Berteloot P, Timmerman D, Van Limbergen E, Weltens C, Van den Bogaert W, Smeets A, Vergote I, Christiaens MR, Drijkoningen M.
    Breast Cancer Res Treat; 2008 Jul 12; 110(1):153-9. PubMed ID: 17687649
    [Abstract] [Full Text] [Related]

  • 14. Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma.
    Fukuda K, Mori M, Uchiyama M, Iwai K, Iwasaka T, Sugimori H.
    Gynecol Oncol; 1998 Jun 12; 69(3):220-5. PubMed ID: 9648591
    [Abstract] [Full Text] [Related]

  • 15. [Mathematical evaluation of prognostic significance of clinico-morphological and immunohistochemical features of endometrioid adenocarcinoma].
    Razorenova TS, Samsonova EA, Pozharisskiĭ KM, Razorenov GI.
    Vopr Onkol; 2007 Jun 12; 53(6):682-9. PubMed ID: 18416138
    [Abstract] [Full Text] [Related]

  • 16. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium.
    Shabani N, Mylonas I, Jeschke U, Thaqi A, Kuhn C, Puchner T, Friese K.
    Anticancer Res; 2007 Jun 12; 27(4A):2027-33. PubMed ID: 17649817
    [Abstract] [Full Text] [Related]

  • 17. Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas.
    Leers MP, Hoop JG, van Beers M, van Rodijnen N, Pannebakker M, Nap M.
    Cytometry B Clin Cytom; 2005 Mar 12; 64(1):43-52. PubMed ID: 15668953
    [Abstract] [Full Text] [Related]

  • 18. Association between HER-2/neu and the progesterone receptor in oestrogen-dependent breast cancer is age-related.
    Huang HJ, Neven P, Drijkoningen M, Paridaens R, Wildiers H, Van Limbergen E, Berteloot P, Amant F, Christiaens MR, Vergote I.
    Breast Cancer Res Treat; 2005 May 12; 91(1):81-7. PubMed ID: 15868434
    [Abstract] [Full Text] [Related]

  • 19. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G, Kalogeras KT, Wirtz RM, Grimani I, Zografos G, Gogas H, Stropp U, Pectasides D, Skarlos D, Hennig G, Samantas E, Bafaloukos D, Papakostas P, Kalofonos HP, Pavlidis N, Fountzilas G.
    Breast Cancer Res Treat; 2009 Jul 12; 116(1):131-43. PubMed ID: 18668363
    [Abstract] [Full Text] [Related]

  • 20. Elevated levels of chemokine receptor CXCR4 in HER-2 negative breast cancer specimens predict recurrence.
    Holm NT, Byrnes K, Li BD, Turnage RH, Abreo F, Mathis JM, Chu QD.
    J Surg Res; 2007 Jul 12; 141(1):53-9. PubMed ID: 17574038
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.